2110 related articles for article (PubMed ID: 8358154)
1. A comparative immunohistochemical study of phaeochromocytomas and paragangliomas.
Fraga M; García-Caballero T; Antúnez J; Couce M; Beiras A; Forteza J
Histol Histopathol; 1993 Jul; 8(3):429-36. PubMed ID: 8358154
[TBL] [Abstract][Full Text] [Related]
2. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
[TBL] [Abstract][Full Text] [Related]
3. Paragangliomas of the head and neck: immunohistochemical neuroendocrine and intermediate filament typing.
Johnson TL; Zarbo RJ; Lloyd RV; Crissman JD
Mod Pathol; 1988 May; 1(3):216-23. PubMed ID: 2467285
[TBL] [Abstract][Full Text] [Related]
4. Expression of neuropeptides and other neuroendocrine markers in human phaeochromocytomas.
Moreno AM; Castilla-Guerra L; Martínez-Torres MC; Torres-Olivera F; Fernández E; Galera-Davidson H
Neuropeptides; 1999 Apr; 33(2):159-63. PubMed ID: 10657486
[TBL] [Abstract][Full Text] [Related]
5. Paragangliomas of the head and neck. Immunohistochemical analysis of 16 cases in comparison with neuro-endocrine carcinomas.
Martinez-Madrigal F; Bosq J; Micheau C; Nivet P; Luboinski B
Pathol Res Pract; 1991 Sep; 187(7):814-23. PubMed ID: 1754507
[TBL] [Abstract][Full Text] [Related]
6. Nonsporadic cases and unusual morphological features in pheochromocytoma and paraganglioma.
Lamovec J; Frković-Grazio S; Bracko M
Arch Pathol Lab Med; 1998 Jan; 122(1):63-8. PubMed ID: 9448019
[TBL] [Abstract][Full Text] [Related]
7. KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
Elder EE; Xu D; Höög A; Enberg U; Hou M; Pisa P; Gruber A; Larsson C; Bäckdahl M
Mod Pathol; 2003 Mar; 16(3):246-55. PubMed ID: 12640105
[TBL] [Abstract][Full Text] [Related]
8. Stathmin immunoreactivity in phaeochromocytomas and paragangliomas: differential expression between benign and malignant neoplasms.
Lin WC; Chen SC; Chuang YT; Kuo KL; Huang KH
Asian J Surg; 2011 Jan; 34(1):15-22. PubMed ID: 21515208
[TBL] [Abstract][Full Text] [Related]
9. Dopamine-secreting phaeochromocytomas and paragangliomas: clinical features and management.
Foo SH; Chan SP; Ananda V; Rajasingam V
Singapore Med J; 2010 May; 51(5):e89-93. PubMed ID: 20593136
[TBL] [Abstract][Full Text] [Related]
10. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of S-100 protein in sustentacular cells of phaeochromocytomas and paragangliomas.
Schroder HD; Johannsen L
Histopathology; 1986 Oct; 10(10):1023-33. PubMed ID: 3536711
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical identification of neuron-specific enolase, synaptophysin, chromogranin and endocrine granule constituent in neuroendocrine tumours.
Vyberg M; Horn T; Francis D; Askaa J
Acta Histochem Suppl; 1990; 38():179-81. PubMed ID: 1964227
[TBL] [Abstract][Full Text] [Related]
13. Examination of PHOX2B in adult neuroendocrine neoplasms reveals relatively frequent expression in phaeochromocytomas and paragangliomas.
Lee JP; Hung YP; O'Dorisio TM; Howe JR; Hornick JL; Bellizzi AM
Histopathology; 2017 Oct; 71(4):503-510. PubMed ID: 28464318
[TBL] [Abstract][Full Text] [Related]
14. Phaeochromocytomas and paragangliomas: A difference in disease behaviour and clinical outcomes.
Ezzat Abdel-Aziz T; Prete F; Conway G; Gaze M; Bomanji J; Bouloux P; Khoo B; Caplin M; Mushtaq I; Smart J; Kurzawinski TR
J Surg Oncol; 2015 Oct; 112(5):486-91. PubMed ID: 26337393
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratins expression in paragangliomas of the cauda equina.
Labrousse F; Leboutet MJ; Petit B; Paraf F; Boncoeur-Martel MP; Moreau JJ; Catanzano G
Clin Neuropathol; 1999; 18(4):208-13. PubMed ID: 10442464
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical demonstration of chromogranin A, chromogranin B, and secretogranin II in extra-adrenal paragangliomas.
Schmid KW; Schröder S; Dockhorn-Dworniczak B; Kirchmair R; Tötsch M; Böcker W; Fischer-Colbrie R
Mod Pathol; 1994 Apr; 7(3):347-53. PubMed ID: 8058707
[TBL] [Abstract][Full Text] [Related]
17. Paragangliomas: assessment of prognosis by histologic, immunohistochemical, and ultrastructural techniques.
Kliewer KE; Wen DR; Cancilla PA; Cochran AJ
Hum Pathol; 1989 Jan; 20(1):29-39. PubMed ID: 2912871
[TBL] [Abstract][Full Text] [Related]
18. A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma.
Sangoi AR; McKenney JK
Am J Surg Pathol; 2010 Mar; 34(3):423-32. PubMed ID: 20154585
[TBL] [Abstract][Full Text] [Related]
19. Bronchial carcinoids with S-100 positive sustentacular cells. A comparative study with gastrointestinal carcinoids, pheochromocytomas and paragangliomas.
Barbareschi M; Frigo B; Mosca L; Carboni N; Arrigoni GP; Leonardi E; Wilander E; Siegal GP; Shiro BC
Pathol Res Pract; 1990 Apr; 186(2):212-22. PubMed ID: 2188235
[TBL] [Abstract][Full Text] [Related]
20. Cytokeratin expression in adrenal phaeochromocytomas and extra-adrenal paragangliomas.
Chetty R; Pillay P; Jaichand V
J Clin Pathol; 1998 Jun; 51(6):477-8. PubMed ID: 9771451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
